[Advances in the treatment of Clostridium difficile infection in children]. / å¿ç«¥è°é¾æ¢èææçæ²»çè¿å±.
Zhongguo Dang Dai Er Ke Za Zhi
; 26(9): 995-1001, 2024.
Article
em Zh
| MEDLINE
| ID: mdl-39267518
ABSTRACT
Clostridium difficile infection (CDI) is a major cause of hospital-acquired gastrointestinal infections in children. Current treatment for pediatric CDI primarily involves antibiotics; however, some children experience recurrence after antibiotic treatment, and those with initial recurrence remain at risk for further recurrences following subsequent antibiotic therapy. In such cases, careful consideration of treatment options is necessary. Fecal microbiota transplantation has been shown to be effective for recurrent CDI and has a high safety profile. This article reviews the latest research on the pathogenesis, risk factors, diagnosis, and treatment of pediatric CDI domestically and internationally, with a particular focus on fecal microbiota transplantation therapy.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Infecções por Clostridium
/
Transplante de Microbiota Fecal
Limite:
Child
/
Humans
Idioma:
Zh
Ano de publicação:
2024
Tipo de documento:
Article